IBDEI1NK ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,26390,1,4,0)
;;=4^E11.41
;;^UTILITY(U,$J,358.3,26390,2)
;;=^5002645
;;^UTILITY(U,$J,358.3,26391,0)
;;=E11.42^^107^1241^13
;;^UTILITY(U,$J,358.3,26391,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26391,1,3,0)
;;=3^DM Type 2 w/ Diab Polyneuropathy
;;^UTILITY(U,$J,358.3,26391,1,4,0)
;;=4^E11.42
;;^UTILITY(U,$J,358.3,26391,2)
;;=^5002646
;;^UTILITY(U,$J,358.3,26392,0)
;;=E11.43^^107^1241^2
;;^UTILITY(U,$J,358.3,26392,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26392,1,3,0)
;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,26392,1,4,0)
;;=4^E11.43
;;^UTILITY(U,$J,358.3,26392,2)
;;=^5002647
;;^UTILITY(U,$J,358.3,26393,0)
;;=E11.44^^107^1241^1
;;^UTILITY(U,$J,358.3,26393,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26393,1,3,0)
;;=3^DM Type 2 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,26393,1,4,0)
;;=4^E11.44
;;^UTILITY(U,$J,358.3,26393,2)
;;=^5002648
;;^UTILITY(U,$J,358.3,26394,0)
;;=E11.49^^107^1241^8
;;^UTILITY(U,$J,358.3,26394,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26394,1,3,0)
;;=3^DM Type 2 w/ Diab Neurological Compl
;;^UTILITY(U,$J,358.3,26394,1,4,0)
;;=4^E11.49
;;^UTILITY(U,$J,358.3,26394,2)
;;=^5002649
;;^UTILITY(U,$J,358.3,26395,0)
;;=E11.59^^107^1241^25
;;^UTILITY(U,$J,358.3,26395,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26395,1,3,0)
;;=3^DM Type 2 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,26395,1,4,0)
;;=4^E11.59
;;^UTILITY(U,$J,358.3,26395,2)
;;=^5002652
;;^UTILITY(U,$J,358.3,26396,0)
;;=E11.610^^107^1241^9
;;^UTILITY(U,$J,358.3,26396,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26396,1,3,0)
;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,26396,1,4,0)
;;=4^E11.610
;;^UTILITY(U,$J,358.3,26396,2)
;;=^5002653
;;^UTILITY(U,$J,358.3,26397,0)
;;=E11.618^^107^1241^26
;;^UTILITY(U,$J,358.3,26397,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26397,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,26397,1,4,0)
;;=4^E11.618
;;^UTILITY(U,$J,358.3,26397,2)
;;=^5002654
;;^UTILITY(U,$J,358.3,26398,0)
;;=E11.621^^107^1241^16
;;^UTILITY(U,$J,358.3,26398,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26398,1,3,0)
;;=3^DM Type 2 w/ Foot Ulcer
;;^UTILITY(U,$J,358.3,26398,1,4,0)
;;=4^E11.621
;;^UTILITY(U,$J,358.3,26398,2)
;;=^5002656
;;^UTILITY(U,$J,358.3,26399,0)
;;=E11.622^^107^1241^31
;;^UTILITY(U,$J,358.3,26399,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26399,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,26399,1,4,0)
;;=4^E11.622
;;^UTILITY(U,$J,358.3,26399,2)
;;=^5002657
;;^UTILITY(U,$J,358.3,26400,0)
;;=E11.628^^107^1241^30
;;^UTILITY(U,$J,358.3,26400,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26400,1,3,0)
;;=3^DM Type 2 w/ Oth Skin Compl
;;^UTILITY(U,$J,358.3,26400,1,4,0)
;;=4^E11.628
;;^UTILITY(U,$J,358.3,26400,2)
;;=^5002658
;;^UTILITY(U,$J,358.3,26401,0)
;;=E11.630^^107^1241^33
;;^UTILITY(U,$J,358.3,26401,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26401,1,3,0)
;;=3^DM Type 2 w/ Periodontal Disease
;;^UTILITY(U,$J,358.3,26401,1,4,0)
;;=4^E11.630
;;^UTILITY(U,$J,358.3,26401,2)
;;=^5002659
;;^UTILITY(U,$J,358.3,26402,0)
;;=E11.638^^107^1241^29
;;^UTILITY(U,$J,358.3,26402,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26402,1,3,0)
;;=3^DM Type 2 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,26402,1,4,0)
;;=4^E11.638
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1NK 3759 printed Oct 16, 2024@18:13 Page 2
IBDEI1NK ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,26390,1,4,0)
+2 ;;=4^E11.41
+3 ;;^UTILITY(U,$J,358.3,26390,2)
+4 ;;=^5002645
+5 ;;^UTILITY(U,$J,358.3,26391,0)
+6 ;;=E11.42^^107^1241^13
+7 ;;^UTILITY(U,$J,358.3,26391,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,26391,1,3,0)
+10 ;;=3^DM Type 2 w/ Diab Polyneuropathy
+11 ;;^UTILITY(U,$J,358.3,26391,1,4,0)
+12 ;;=4^E11.42
+13 ;;^UTILITY(U,$J,358.3,26391,2)
+14 ;;=^5002646
+15 ;;^UTILITY(U,$J,358.3,26392,0)
+16 ;;=E11.43^^107^1241^2
+17 ;;^UTILITY(U,$J,358.3,26392,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,26392,1,3,0)
+20 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
+21 ;;^UTILITY(U,$J,358.3,26392,1,4,0)
+22 ;;=4^E11.43
+23 ;;^UTILITY(U,$J,358.3,26392,2)
+24 ;;=^5002647
+25 ;;^UTILITY(U,$J,358.3,26393,0)
+26 ;;=E11.44^^107^1241^1
+27 ;;^UTILITY(U,$J,358.3,26393,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,26393,1,3,0)
+30 ;;=3^DM Type 2 w/ Diab Amyotrophy
+31 ;;^UTILITY(U,$J,358.3,26393,1,4,0)
+32 ;;=4^E11.44
+33 ;;^UTILITY(U,$J,358.3,26393,2)
+34 ;;=^5002648
+35 ;;^UTILITY(U,$J,358.3,26394,0)
+36 ;;=E11.49^^107^1241^8
+37 ;;^UTILITY(U,$J,358.3,26394,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,26394,1,3,0)
+40 ;;=3^DM Type 2 w/ Diab Neurological Compl
+41 ;;^UTILITY(U,$J,358.3,26394,1,4,0)
+42 ;;=4^E11.49
+43 ;;^UTILITY(U,$J,358.3,26394,2)
+44 ;;=^5002649
+45 ;;^UTILITY(U,$J,358.3,26395,0)
+46 ;;=E11.59^^107^1241^25
+47 ;;^UTILITY(U,$J,358.3,26395,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,26395,1,3,0)
+50 ;;=3^DM Type 2 w/ Oth Circulatory Compl
+51 ;;^UTILITY(U,$J,358.3,26395,1,4,0)
+52 ;;=4^E11.59
+53 ;;^UTILITY(U,$J,358.3,26395,2)
+54 ;;=^5002652
+55 ;;^UTILITY(U,$J,358.3,26396,0)
+56 ;;=E11.610^^107^1241^9
+57 ;;^UTILITY(U,$J,358.3,26396,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,26396,1,3,0)
+60 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
+61 ;;^UTILITY(U,$J,358.3,26396,1,4,0)
+62 ;;=4^E11.610
+63 ;;^UTILITY(U,$J,358.3,26396,2)
+64 ;;=^5002653
+65 ;;^UTILITY(U,$J,358.3,26397,0)
+66 ;;=E11.618^^107^1241^26
+67 ;;^UTILITY(U,$J,358.3,26397,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,26397,1,3,0)
+70 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
+71 ;;^UTILITY(U,$J,358.3,26397,1,4,0)
+72 ;;=4^E11.618
+73 ;;^UTILITY(U,$J,358.3,26397,2)
+74 ;;=^5002654
+75 ;;^UTILITY(U,$J,358.3,26398,0)
+76 ;;=E11.621^^107^1241^16
+77 ;;^UTILITY(U,$J,358.3,26398,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,26398,1,3,0)
+80 ;;=3^DM Type 2 w/ Foot Ulcer
+81 ;;^UTILITY(U,$J,358.3,26398,1,4,0)
+82 ;;=4^E11.621
+83 ;;^UTILITY(U,$J,358.3,26398,2)
+84 ;;=^5002656
+85 ;;^UTILITY(U,$J,358.3,26399,0)
+86 ;;=E11.622^^107^1241^31
+87 ;;^UTILITY(U,$J,358.3,26399,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,26399,1,3,0)
+90 ;;=3^DM Type 2 w/ Oth Skin Ulcer
+91 ;;^UTILITY(U,$J,358.3,26399,1,4,0)
+92 ;;=4^E11.622
+93 ;;^UTILITY(U,$J,358.3,26399,2)
+94 ;;=^5002657
+95 ;;^UTILITY(U,$J,358.3,26400,0)
+96 ;;=E11.628^^107^1241^30
+97 ;;^UTILITY(U,$J,358.3,26400,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,26400,1,3,0)
+100 ;;=3^DM Type 2 w/ Oth Skin Compl
+101 ;;^UTILITY(U,$J,358.3,26400,1,4,0)
+102 ;;=4^E11.628
+103 ;;^UTILITY(U,$J,358.3,26400,2)
+104 ;;=^5002658
+105 ;;^UTILITY(U,$J,358.3,26401,0)
+106 ;;=E11.630^^107^1241^33
+107 ;;^UTILITY(U,$J,358.3,26401,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,26401,1,3,0)
+110 ;;=3^DM Type 2 w/ Periodontal Disease
+111 ;;^UTILITY(U,$J,358.3,26401,1,4,0)
+112 ;;=4^E11.630
+113 ;;^UTILITY(U,$J,358.3,26401,2)
+114 ;;=^5002659
+115 ;;^UTILITY(U,$J,358.3,26402,0)
+116 ;;=E11.638^^107^1241^29
+117 ;;^UTILITY(U,$J,358.3,26402,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,26402,1,3,0)
+120 ;;=3^DM Type 2 w/ Oth Oral Compl
+121 ;;^UTILITY(U,$J,358.3,26402,1,4,0)
+122 ;;=4^E11.638
